ArticleRomanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
Acute pulmonary inflammatory reaction in COVID-19 - histological and immunohistochemical study.
Article in Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Neurological symptoms observed in patients with COVID-19.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologieArticle
- Brain histopathological changes caused by SARS-CoV-2 infection.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologieArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coronavirus disease 2029 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which enters the human body via the respiratory route and can infect nasal and bronchial epithelial cells, goblet cells, hair cells, pneumocytes, etc. COVID-19 caused the worst pandemic in centuries. SARS-CoV-2, once in the airway tree, penetrates the host cells and causes a strong inflammatory reaction by a rapid response of the innate immune system, in particular by activation of macrophages and dendritic cells that recognize the virus component proteins as non-self. Cells of the immune system secrete type I interferon and proinflammatory cytokines, initiating an antiviral state in neighboring cells and in the intercellular connective matrix, recruiting new immune mediators and new cells to the site of infection. This rapid response is crucial for limiting the spread of SARS-CoV-2. In the present study, we aimed at highlighting some microscopic aspects of the acute inflammatory reaction in the lung for SARS-CoV-2 infection. The analysis of the histological pieces suggested that the pulmonary inflammatory reaction begins with the accumulation of immune cells in the interalveolar septa in response to viral insult, congestion of pulmonary vessels with increased blood volume in pulmonary vessels, followed by the presence of alveolar exudate, which reduces the area of hematosis and triggers respiratory symptoms. The inflammatory reaction was totally inhomogeneous, varying widely from patient to patient and even within the same patient, probably depending on the immune status, age or comorbidities. It presented two phases, a predominantly exudative phase (EP) and a predominantly proliferative phase (PP), intricately intertwined; sometimes, on the same histopathological piece, we identified both areas of incipient inflammatory reaction (EP) and a very intense reaction in the PP, suggesting that the pulmonary inflammatory reaction developed rapidly. The inflammatory infiltrate had a complex composition: neutrophilic leukocytes, macrophages, mast cells, lymphocytes and plasma cells. The most abundant inflammatory cells were macrophages, both in the EP and PP. The use of anti-interleukin (IL) antibodies showed that ILs are mainly produced by cells of the monocyte-macrophage system, but also by conjunctival cells (fibroblasts).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.